Geoffrey M. Curtis Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Geoffrey M. Curtis is EVP, Corporate Affairs, CCO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 52,675 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Apr 01, 2021, when has been sold 70,739 shares (Ordinary Shares) at a price of $93.51 per share, resulting in proceeds of $6,614,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.7K

0% 3M change

0% 12M change

Total Value Held $0

GEOFFREY M. CURTIS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2021	SELL Open market or private sale	$6,614,804 $93.51 p/Share	70,739 Reduced 57.32%	52,675 Ordinary Shares
Apr 01 2021	BUY Exercise of conversion of derivative security	$1,048,210 $28.33 p/Share	37,000 Added 23.07%	123,414 Ordinary Shares
Feb 17 2021	SELL Payment of exercise price or tax liability	$60,670 $87.17 p/Share	696 Reduced 0.8%	86,414 Ordinary Shares
Feb 17 2021	BUY Grant, award, or other acquisition	-	1,571 Added 1.77%	87,110 Ordinary Shares
Jan 21 2021	SELL Payment of exercise price or tax liability	$128,998 $77.43 p/Share	1,666 Reduced 1.91%	85,539 Ordinary Shares
Jan 21 2021	BUY Exercise of conversion of derivative security	-	3,760 Added 4.13%	87,205 Ordinary Shares
Jan 05 2021	SELL Payment of exercise price or tax liability	$2,549,045 $73.28 p/Share	34,785 Reduced 29.51%	83,088 Ordinary Shares
Jan 05 2021	BUY Grant, award, or other acquisition	-	47,795 Added 28.85%	117,873 Ordinary Shares
Jan 05 2021	BUY Exercise of conversion of derivative security	-	34,881 Added 33.23%	70,078 Ordinary Shares
May 26 2020	SELL Open market or private sale	$1,092,612 $49.85 p/Share	21,918 Reduced 38.62%	34,834 Ordinary Shares
May 13 2020	SELL Bona fide gift	-	5,720 Reduced 9.16%	56,752 Ordinary Shares
Feb 19 2020	SELL Payment of exercise price or tax liability	$163,496 $36.06 p/Share	4,534 Reduced 6.77%	62,472 Ordinary Shares
Feb 19 2020	BUY Grant, award, or other acquisition	-	10,232 Added 13.25%	67,006 Ordinary Shares
Jan 21 2020	SELL Payment of exercise price or tax liability	$67,779 $38.25 p/Share	1,772 Reduced 3.02%	56,906 Ordinary Shares
Jan 21 2020	BUY Grant, award, or other acquisition	-	3,998 Added 6.38%	58,678 Ordinary Shares
Jan 05 2020	SELL Payment of exercise price or tax liability	$487,964 $36.1 p/Share	13,517 Reduced 19.82%	54,680 Ordinary Shares
Jan 05 2020	BUY Grant, award, or other acquisition	-	14,259 Added 17.29%	68,197 Ordinary Shares
Jan 05 2020	BUY Exercise of conversion of derivative security	-	25,205 Added 31.85%	53,938 Ordinary Shares
Aug 08 2019	SELL Open market or private sale	$547,787 $26.58 p/Share	20,609 Reduced 42.07%	28,382 Ordinary Shares
Aug 01 2019	SELL Payment of exercise price or tax liability	$331,851 $24.97 p/Share	13,290 Reduced 21.34%	48,991 Ordinary Shares
Aug 01 2019	BUY Exercise of conversion of derivative security	-	30,000 Added 32.51%	62,281 Ordinary Shares
Jun 12 2019	SELL Bona fide gift	-	1,265 Reduced 3.77%	32,281 Ordinary Shares
Apr 08 2019	SELL Payment of exercise price or tax liability	$84,223 $27.16 p/Share	3,101 Reduced 8.65%	32,766 Ordinary Shares
Apr 08 2019	BUY Exercise of conversion of derivative security	-	7,000 Added 16.33%	35,867 Ordinary Shares
Feb 25 2019	SELL Open market or private sale	$213,898 $21.22 p/Share	10,080 Reduced 25.88%	28,867 Ordinary Shares

GMC

Geoffrey M. Curtis

EVP, Corporate Affairs, CCO

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Value

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP

Account